Health and Quality of Life of ITMO University's Students, Faculty and Staff

March 4, 2024 updated by: ITMO University

Selected Health and Quality of Life Indicators Among ITMO University Students, Faculty and Staff

This study assess various indicators of physical and mental health, quality of life, well-being and satisfaction among students, faculty and staff of ITMO University. Participants are invited to join the study via informational web-site. Several quality of life indicators are obtained via surveys and some blood samples are taken to assess health condition.

Study Overview

Status

Completed

Conditions

Detailed Description

Students, faculty and staff from ITMO University are invited to participate in health examination on the campus. Surveys, such as EQ-5D-5L, K10+OHQ29, PSQI and others, assess different aspects of quality of life related to health. Also participants are asked to undergo several measurements by the interviewer (waist, hips, height, weight and others). Moreover blood samples are taken from the participants and lipidogram, cholesterol and glycohemoglobin are checked.

Study Type

Observational

Enrollment (Actual)

830

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Students, faculty and staff from ITMO University

Description

Inclusion Criteria:

  • student, faculty or staff from ITMO University
  • participants, who signed informed consent and consent for data gathering
  • participants, who signed consent to enroll in following surveys and health check-ups

Exclusion Criteria:

  • participants younger than 16 years old
  • participants with acute conditions distorting quality of life assessment
  • participants, who did not sign informed consent and consent for data gathering - participants, who did not sign consent to enroll in following surveys and health check-ups

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Healthy adults (16+)
Healthy students, faculty and staff of ITMO University older than 16 years

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cholesterol
Time Frame: 30 days
Measured by A15 biochemical automatic analyzer (Biosystem, Spain)
30 days
Lipidogram
Time Frame: 30 days
Measured by A15 biochemical automatic analyzer (Biosystem, Spain)
30 days
Glycohemoglobin
Time Frame: 30 days
Measured by Architect c8000
30 days
Distress
Time Frame: 30 days
Global measure of distress based on questions about anxiety and depressive symptoms that a person has experienced in the most recent 4 week period measured by Kessler-10 questionnaire
30 days
Psychological well-being
Time Frame: 30 days
Measured by Oxford Happiness Questionnaire (OHQ)
30 days
Health status and quality of life
Time Frame: 30 days
Measured by EuroQOL-5 Dimension Questionnaire (EQ-5D-5L)
30 days
Nicotine dependence
Time Frame: 30 days
Nicotine dependence across all nicotine product types including cigarettes and electronic cigarettes measured by The Penn State Nicotine Dependence Index
30 days
Diabetes risk score
Time Frame: 30 days
The 10-year risk of type 2 diabetes mellitus (DM), including asymptomatic diabetes mellitus and impaired glucose tolerance (IGT) measured by The Finnish Diabetes Risk Score
30 days
Sleep quality and disturbances.
Time Frame: 30 days
Measured by Pittsburgh Sleep Quality Index
30 days
Physical activity
Time Frame: 30 days
The types of intensity of physical activity and sitting time that people do as part of their daily lives measured by International Physical Activity Questionnaire - Short Form
30 days
Emotional eating, external eating, and restrained eating behavior
Time Frame: 30 days
Qualitative and quantitative assessment of eating disorders associated with overeating and accompanying obesity measured by Dutch Eating Behavior Questionnaire
30 days
Alcohol use
Time Frame: 30 days
Problematic alcohol use, including possible alcohol use disorders measured by The Russian version of the Alcohol Use Disorders Identification Test (AUDIT)
30 days
Ischemic heart disease prediction
Time Frame: 30 days
Measured by The Rose angina screening questionnaire
30 days
Retinopathy
Time Frame: 30 days
Measured with non-mydriatic fundus camera
30 days
Ocular fundus condition
Time Frame: 30 days
Measured with non-mydriatic fundus camera
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 2, 2022

Primary Completion (Actual)

March 31, 2023

Study Completion (Actual)

December 31, 2023

Study Registration Dates

First Submitted

May 24, 2022

First Submitted That Met QC Criteria

May 24, 2022

First Posted (Actual)

May 27, 2022

Study Record Updates

Last Update Posted (Estimated)

March 5, 2024

Last Update Submitted That Met QC Criteria

March 4, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 922022/4.3.1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Subscribe